Pfizer(PFE)
Focus: Pfizer is a $59.6B global pharmaceutical giant headquartered in New York with 88,000 employees, specializing in oncology, immunology, rare diseases, vaccines, and internal medicine across solid oral dosage forms. It is a publicly traded company (PFE) with a diversified portfolio and significant manufacturing scale.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
88,000
Open Jobs
507+201 this month
Hot — 1035 jobs added in 30d
Net +201 (1035 new, 834 removed). Aggressive expansion phase.
Recent layoff filing — 100 affected
- 8/25/2025 — Bothell, WA · 100 affected · Layoff
Source: state DOL filings via Big Local News
Should You Work at Pfizer?
AI assessmentPfizer offers blockbuster product exposure and R&D depth but faces near-term patent cliff pressures and dramatic revenue decline that may trigger further restructuring; best for professionals seeking established oncology/immunology expertise willing to navigate transition risk.
Why Work Here
- Access to blockbuster franchises: IBRANCE ($2.0B Part D), VYNDAMAX ($1.3B), and XELJANZ XR ($586M) provide exposure to peak-stage commercial success in oncology and rare disease.
Data completeness
7/9 — Strong
Company HealthWatch
Pipeline
Early-stage
50 total
LOE Risk
8 imminent
AMITIZA
Hiring
Slowing
Jobs decreasing
Key Products
$2.0B Part DStable
Peak
Help build intelligence for Pfizer
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.